Recruiting Geographic Atrophy Studies in Oakland
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TP...
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of GM1 gan...
About Geographic Atrophy Clinical Trials in Oakland
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 2 geographic atrophy clinical trials recruiting participants in Oakland, CALIFORNIA. These studies are seeking a combined 1,605 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Azafaros A.G.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Oakland — FAQ
Are there geographic atrophy clinical trials in Oakland?
Yes, there are 2 geographic atrophy clinical trials currently recruiting in Oakland, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Oakland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you about next steps.
Are clinical trials in Oakland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oakland studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 2 active trials in Oakland are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov